a novel solid pharmaceutical dispersion that improves the bioavailability of poorly water soluble drugs is produced by combining the drug with a polymer carrier such as polyvinylpyrrolidone . the drug is combined with the carrier without the need for using organic solvents or melting temperatures through the use of a transition compound such as polyethylene glycol which partially solubilizes the drug and / or plasticizes the polymer .